Risperidone

Product description

Risperidone is an active substance from the group of neuroleptics for the treatment of schizophrenia and other psychiatric and psychotic disorders. It is administered in the form of film-coated tablets, melting tablets, as an oral solution and as a solution for injection.

Comprehensive documentation for drug registration of Risperidone can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
106266-06-2 CEP, USDMF EP

Tradename(s)

Risperidone (Antipsychotic/ Neuroleptic)

Country availability

Available worldwide

Lidia Vereckei

Contact person

Lidia Vereckei

General Manager


email   phone